Astia
VC Fund
Palo Alto, United States
Astia is a VC fund in Palo Alto focused on FinTech and Health Care. Astia focuses on sourcing and investing in women-led companies through its various investment vehicles, including Astia Fund and Astia Angels. Utilizing a data-driven methodology, Astia aims to eliminate bias in the investment process while supporting entrepreneurs with diverse backgrounds. The organization is committed to leveling the investmentplaying field and fostering inclusive teams that drive impactful growth.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 7%
Last updated:
For AI agents: llms.txt
Industries Astia invests in
Stages Astia invests in
Countries Astia invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brian Evje
|
|||
|
Evie Mulberry
|
|||
Heather Furby
|
|||
Jodi Akin
|
|||
Lena Rosenior
|
Investment Focus
Industry
- FinTech 3 (20%)
- Health Care 3 (20%)
- Financial Services 3 (20%)
- Medical 2 (13%)
- Women's 2 (13%)
Stage
- Series A 6 (40%)
- Series B 4 (27%)
- Seed 3 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Brian Evje
Executive Consultant, Leadership & Organizaton
|
Executive Consultant, Leadership & Organizaton | Total investments: 0 | Find email | |
|
Evie Mulberry
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Heather Furby
C-Suite Screening Committee
|
C-Suite Screening Committee | Total investments: 0 | Find email | |
|
Jodi Akin
Angel Investor; Screening/Advisory
|
Angel Investor; Screening/Advisory | Total investments: 0 | Find email | |
|
Lena Rosenior
Advisor
|
Advisor | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aralez Bio
|
Aralez Bio uses engineered enzymes to make valuable products in a sustainable way.The company has invented a novel enzymatic method for synthesizing noncanonical amino acids (ncAAs) also called unusual or unnatural amino acids. Its proprietary approach enables over 100 ncAAs to be synthesized with perfect enantiopurity in just a single step, withwater as the only byproduct | $12M / Series A / Oct 29, 2024 | |
Mae Health
|
Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes. | Seed / May 07, 2024 | |
Goalsetter
|
Goalsetter is a goal-based savings and gifting platform, made just for kids and powered by those who love them. It combines the best of goal-based savings platforms like Digit and Acorns with the best of gift-registries like Zola and Honeyfund, and in so doing, targets the millennial mom with a platform that enables families to contribute to kids’future goals instead of buying them more consumer goods. In turn, Goalsetter becomes a savings vehicle for kids, turning first-time savers into all-the-time savers and giving kids healthy financial habits that will last a lifetime. | $9.6M / Series A / Mar 25, 2024 | |
AOA
|
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M / Series A / Oct 11, 2023 | |
Catch+Release
|
Catch&Release is an end-to-end content licensing platform that enables brands and advertisers to license content from anywhere on the internet. Streamline the clearance and licensing process within the Content Exchange, a licensing platform where users can organize shots from anywhere on the internet, receive Clearance Ratings to understandwhat content is licensable, and initiate clearances and licensing at the click of a button. Catch&Release negotiates copyright and model clearances on your behalf, provides indemnification, and keeps track of all documentation, transactions, and license data. | $8.8M / Series A / Aug 08, 2023 | |
Candesant Biomedical
|
Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Itsdevice is designed to target and inactivate the most active sweat glands.The company was founded in 2016 and is headquartered in San Francisco, California. | $35M / Series B / Jun 06, 2023 | |
Repurpose
|
Repurpose is a consumer packaged goods company used to make plant-based compostable products as an alternative to disposable plasticware. Its tableware is made from plants and compostable materials and are durable and compostable materials that enable users to reduce the number of plastics in the environment and use guilt-free renewablealternatives and in turn, improve their health. | Series B / May 01, 2023 | |
CNote
|
CNote is an investment platform that earns a better return while investing in the causes and communities that matters.CNote rewards great savers with alternative financial vehicles that earn more - safely and simply. Their first product, CNote Savings, helps good savers earn up to 2.5% annual return -- that's 35x more than a traditionalsavings account.The was founded in 2016 by two women with decades of experience working in finance, venture capital, and private equity. CNote is headquartered in Oakland, California. | $7.3M / Series A / Sep 19, 2022 | |
Ellevest
|
Ellevest provides an engaging investing experience to help women meet their financial goals in life.Ellevest offers a modern, engaging user experience. The same care, thoughtfulness, and attention to detail that is reflected in its beautiful, easy-to-use interface are applied to the construction of its portfolios, its selection of investments,and the development of the algorithms that drive its forecasts and recommendations. | $53M / Series B / Apr 06, 2022 | |
Pallet
|
Pallet is a social purpose corporation that builds equal opportunity access to housing and employment. Pallet provides portable shelter systems intended to prevent and reduce homelessness. The company's shelter is made from durable aluminum and composite materials, giving customers with high quality, cost-effective, and portable sheltersystems.Pallet is headquartered in Seattle, Washington. | $15M / Series A / Mar 15, 2022 | |
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Astia invest in?
Astia invests primarily in FinTech, Health Care and Financial Services startups, most often at Series A and Series B stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Astia?
Public channels for Astia include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Astia?
The team at Astia includes Brian Evje (Executive Consultant, Leadership & Organizaton), Evie Mulberry (Managing Director) and Heather Furby (C-Suite Screening Committee), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
